Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
This study has been suspended.
( Based on an interim data review, the DSMB concluded that the vaccine cannot be shown in this trial to prevent HIV infection or affect the course of the disease. )
Study NCT00486408
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: June 12, 2007
Last Updated: September 9, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
